We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Genomic Tool Supports Analysis of Repeat Expansions Linked to Inherited Disorders

By LabMedica International staff writers
Posted on 20 Oct 2026

Repeat expansions are associated with numerous inherited disorders, but they can be difficult to characterize in genomic research. More...

Analysis may need to capture not only expansion size but also how expansion sizes are distributed within alleles. A newly launched analysis pipeline now uses electronic genome mapping data to investigate disease-associated repeat expansions.

Nabsys (Nabsys 2.0, LLC; Providence, RI, USA) has released RepX, a repeat expansion analysis pipeline available through the Nabsys Navigator cloud platform. RepX uses Electronic Genome Mapping (EGM) data generated on the OhmX Platform. The pipeline is designed to investigate disease-associated repeat expansions using data produced by the company’s standard workflow.

EGM analyzes individual ultra-long DNA molecules without amplification or ligation. This approach avoids biases associated with those processes and enables researchers to examine the distribution of expansion sizes. It also supports investigation of repeat instability within each allele, providing single-molecule information relevant to repeat expansion research.

Because RepX runs on data from the standard OhmX VOLT Whole Genome Kit, the same dataset can support genome-wide structural variant and copy number variant analyses. Within Nabsys Navigator, RepX joins SV-Discover for genome-wide structural variant analysis and SV-Verify for confirmation of structural variants identified by other technologies. The platform also includes integrated visualization tools to support these analyses.

Nabsys will demonstrate RepX and Nabsys Navigator during the American Society of Human Genetics (ASHG) 2026 Annual Meeting, taking place October 20-24 in Montréal, Canada. The company’s five posters include “CRISPR/Cas9 Customization of Electronic Genome Mapping Repeat Expansion Assays” and the Reviewers’ Choice poster “CRISPR/Cas9 Optimization by Electronic Genome Mapping.” The OhmX Platform, Nabsys Navigator, and RepX are for Research Use Only and are not for use in diagnostic procedures.

“Repeat expansion research benefits from understanding not just expansion size, but how it varies within an allele. RepX pairs those EGM single-molecule insights with the potential for low-cost, multi-locus analysis—advancing our goal of making single-molecule genomics accessible to every lab,” said Barrett Bready, M.D., founder and CEO of Nabsys.

Related Links
Nabsys


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gastrointestinal Panel
Xpert® GI Panel
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The MIRAM GAGome Kit quantifies urine CS disaccharides by UHPLC-MS/MS, supporting exploratory and translational research across disease areas. (Photo courtesy of Elypta)

Study Finds Urine Biomarker Score Improves Five-Year Cancer Risk Prediction

Cancer risk stratification in healthy adults often relies on established factors such as age and smoking history. However, several cancers highlighted in the study, including pancreatic, kidney, and brain... Read more

Molecular Diagnostics

view channel
Image: A blood test measuring circulating tumor DNA may help identify men with hormone-resistant oligoprogressive prostate cancer most likely to benefit from stereotactic body radiotherapy (Image Credit: Adobe Stock)

Blood Test Identifies Candidates for Targeted Radiotherapy in Advanced Prostate Cancer

Advanced prostate cancer can progress despite hormone-based treatment, with imaging sometimes revealing only limited areas of active disease. For men with hormone-resistant oligoprogressive prostate cancer,... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.